O. S. Shapoval and L. L. Vorontsova, “Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors”, J Educ Health Sport, vol. 5, no. 1, pp. 75–86, Jan. 2015.